1 | technical storage or access | | | | | | | 5 | 1.81% |
2 | generous mission of alpen | | | | | | | 3 | 1.08% |
3 | mission of alpen pharma | | | | | | | 3 | 1.08% |
4 | alpen pharma that defines | | | | | | | 3 | 1.08% |
5 | health generous mission of | | | | | | | 3 | 1.08% |
6 | storage or access is | | | | | | | 3 | 1.08% |
7 | of alpen pharma that | | | | | | | 3 | 1.08% |
8 | or access that is | | | | | | | 2 | 0.72% |
9 | access that is used | | | | | | | 2 | 0.72% |
10 | that is used exclusively | | | | | | | 2 | 0.72% |
11 | pharma that defines our | | | | | | | 2 | 0.72% |
12 | the subscriber or user | | | | | | | 2 | 0.72% |
13 | is used exclusively for | | | | | | | 2 | 0.72% |
14 | by the subscriber or | | | | | | | 2 | 0.72% |
15 | that defines our work | | | | | | | 2 | 0.72% |
16 | the technical storage or | | | | | | | 2 | 0.72% |
17 | of health generous mission | | | | | | | 2 | 0.72% |
18 | name of health generous | | | | | | | 2 | 0.72% |
19 | necessary for the legitimate | | | | | | | 2 | 0.72% |
20 | in the name of | | | | | | | 2 | 0.72% |
21 | storage or access that | | | | | | | 2 | 0.72% |
22 | or user statistics statistics | | | | | | | 1 | 0.36% |
23 | alpenpharmacom en site name | | | | | | | 1 | 0.36% |
24 | user statistics statistics the | | | | | | | 1 | 0.36% |
25 | not requested by the | | | | | | | 1 | 0.36% |
26 | used exclusively for statistical | | | | | | | 1 | 0.36% |
27 | purposes the technical storage | | | | | | | 1 | 0.36% |
28 | anonymous statistical purposes without | | | | | | | 1 | 0.36% |
29 | statistical purposes without a | | | | | | | 1 | 0.36% |
30 | purposes without a subpoena | | | | | | | 1 | 0.36% |
31 | without a subpoena voluntary | | | | | | | 1 | 0.36% |
32 | a subpoena voluntary compliance | | | | | | | 1 | 0.36% |
33 | on the part of | | | | | | | 1 | 0.36% |
34 | the part of your | | | | | | | 1 | 0.36% |
35 | subscriber or user statistics | | | | | | | 1 | 0.36% |
36 | legitimate purpose of storing | | | | | | | 1 | 0.36% |
37 | storing preferences that are | | | | | | | 1 | 0.36% |
38 | the sole purpose of | | | | | | | 1 | 0.36% |
39 | enabling the use of | | | | | | | 1 | 0.36% |
40 | the use of a | | | | | | | 1 | 0.36% |